Related Experiment Video
Updated: Aug 10, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease
Corey A Siegel1,2, Lori S Siegel2, Marla C Dubinsky2,3
1Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Insights
The CDPATH tool effectively predicts Crohn's disease complications. This validated clinical decision support tool aids in assessing patient risk for better management of Crohn's disease.
Area of Science:
- Gastroenterology
- Clinical Decision Support Systems
- Predictive Analytics in Medicine
Background:
- Crohn's disease (CD) patients face significant risks of serious complications.
- Accurate risk assessment is crucial for managing CD and preventing adverse outcomes.
Purpose of the Study:
- To evaluate the performance characteristics of the CDPATH tool in assessing the risk of CD complications.
- To validate CDPATH as a clinical decision support tool for Crohn's disease management.
Main Methods:
- CDPATH, previously known as PROSPECT, was calibrated and validated across two distinct patient cohorts.
- Cox regression and Harrell's C-statistic were employed to assess the tool's predictive accuracy for disease characteristics.
Main Results:
- Significant associations were found between CDPATH components and CD complications in both cohorts, with the exception of perianal location.
- Individualized risk assessment scores generated by CDPATH demonstrated a significant correlation with the occurrence of CD complications.
Conclusions:
- The CDPATH tool has been successfully validated as a reliable clinical decision support system.
- CDPATH provides a valuable means for assessing and predicting the risk of complications in patients with Crohn's disease.
Background:
Patients with Crohn's disease (CD) are at risk of complications. Performance characteristics of a decision support tool assessing the risk of CD complications were evaluated.
Methods:
CDPATH (formerly called the Personalized Risk and Outcome Prediction Tool [PROSPECT]) was calibrated and validated in 2 cohorts. Tool prediction of disease characteristics was assessed using Cox regression and Harrell's C-statistic.
Results:
All associations of CD complications and CDPATH components were significant except perianal location. There was a significant association between individualized risk assessment scores and CD complications in both cohorts.
Conclusion:
CDPATH is validated as a clinical decision support tool for assessing the risk of CD complications.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents